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The  present  investigation  was  undertaken  to  determine  the  frequency, 
rapidity, and level of the homotypic complement-fixing (CF) antibody response 
in monkeys infected with a  Type 2  (Lansing-like) poliomyelitis virus by the 
oral route. This information was sought particularly for the purpose of a compar- 
ison with the Type 2, CF antibodyresponse in patients infected with heterotypic 
Type  1 poliomyelitis virus  (Brunhilde-like strains)  (1).  Previous observations 
(2) on 5 rhesus monkeys convalescent from infection produced by intracerebral 
injection of Type 2 strains, had revealed no CF antibody in one, bled 2 and 26 
days after onset, and  significant titers,  not  higher  than  1:16,  were present 
in 3  of 4  monkeys bled 41  to  162  days after onset.  Although this does  not 
permit any conclusion with regard to the time of appearance of CF antibody 
after infection resulting from intracerebral inoculation of virus, the results are 
in keeping with repeated observations (3, 4)  that the neutralizing antibody in 
such animals usually does not develop until 2 to 3 months after inoculation. 
However, neutralizing antibody has been shown to develop very early after 
infection in monkeys to which virus had been given by mouth (5, 6), a finding 
comparable to the early appearance of this antibody in patients (7, 8). 
The present report presents data on the development of homotypic CF and 
neutralizing  antibodies  in  20  cynomolgus  monkeys  presenting  evidence  of 
paralytic, non-paralytic, or inapparent infections after oral administration of 
Type  2  poliomyelitis virus.  All  the  data  on  these  animals,  except  the  per- 
formance of the CF tests, had been obtained by one of the authors (A.B.S.) 
during  the  course  of another  investigation on  various  problems  relating  to 
infection by the  oral  route. 
* The writers acknowledge  the technical  assistance and cooperation  of Dr. Lenora Brown 
of The Rockefeller  Institute. 
The studies at The Children's  Hospital Research Foundation, University of Cincinnati, 
were aided by a grant from The National Foundation for Infantile Paralysis,  Inc. 
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Materials and Methods 
Infection o/Monkeys by Oral Route.--The Type 2 virus used was the ¥-SK strain obtained 
from Dr. J. L. Melnick as llth mouse passage material. The spinal cords and brain stems of 
paralyzed mice, representing the 12th to 14th passage, were prepared as 10 per cent suspen- 
sion in 0.9 per cent solution of NaCI and stored in the frozen state in a chest containing solid 
CO~. Intracerebral  titrations in mice yielded LD~0 titers of 10  -s.8 to 10  ~.4 for an inoculum 
of 0.03 ml. 
The cynomolgus monkeys used in these tests weighed between 1.5 and 2 kilos. They were 
allowed to drink 2 ml. of the uncentrifuged,  10 per cent virus suspension from a rubber- 
tipped pipette or syringe resting between their teeth, in the morning and afternoon of 3 con- 
secutive days; the total was 12 ml. or approximately 400,000 mouse intracerebral LDl0 of 
virus. As part of another experiment, all but 3 of these monkeys (15-58, 15-61, and 15-62) 
were given 20 hal. of human or cow's milk by mouth from a rubber-tipped  syringe shortly 
before the administration of each dose of virus. The monkeys were bled before the virus 
feedings and at various times thereafter as indicated in Table I. Some were bled immediately 
after  they died. The diagnosis of paralytic poliomyelitis was confirmed by histological ex- 
amination. The monkeys, which exhibited no discernible paralysis or weakness in the gross, 
as well as the surviving paralyzed monkeys were sacrificed 28 days after  the first dose of 
virus and the following  portions of the central nervous system were examined histologically: 
15 to 30 levels of the spinal cord, 6 levels of the medulla, 2 levels of midbrain through the 
colliculi, one level each through the thalamus, hypothalamus,  and anterior perforated sub- 
stance, and partial serial sections of the olfactory bulbs and Gasserian ganglia. None of these 
monkeys exhibited poliomyelitis lesions in the olfactory bulbs or  Gasserian ganglia. The 
lesions present  in the monkeys with non-paralytic poliomyelitis were similar to those pre- 
viously described in rhesus monkeys infected by the intracerebrai route (9, 10). 
Neu.tralization Tests.--These tests were performed in mice, using mixtures consisting of 
serial 5-fold dilutions of mouse-passaged Lansing virus and undiluted serum. The neutraliza- 
tion index is the ratio between the LDs0 titer of the virus in saline solution and in the serum. 
Complement Fixation Tests.--All 40 sera were tested in a single run. The preparation  of 
the antigen and the technique of the test were essentially as previously described (2), except 
for the following: (a) the MEF1 antigen was more potent (up to 32 units) and was therefore 
used diluted to contain 8 to 16 units; (b) since 31 of the 40 sera inactivated at 60°C. for 20 
minutes were anticomplementary  in the  1:2 dilution mad occasionally in higher dilutions, 
the result in the 1:2 dilution was disregarded; (c) some of the sets,  retested after heating 
at 65°C. for 20 minutes, lost their anticomplementary properties and also exhibited a 2- to 
4-fold lower titer of the specific antibody. 
RESLrLTS 
The results are summarized in Table I. Although only monkeys which de- 
veloped neutralizing antibody were included in this investigation, it should be 
noted that by the procedure used only 10 per cent of c~omolgus monkeys fed 
this amount of virus fail to develop neutralizing antibodies (ii). All 13  sur- 
viving monkeys developed CF antibodies by the end of 4 weeks after the first 
dose of virus, regardless of whether their infection was paralytic, non-paralytic, 
or clinically and pathologically inapparent. The  titers of  CF  antibody were 
also of the same order of magnitude in the 3 groups of monkeys. These titers, 
interestingly enough,  are  not higher than those  encountered in patients in- 
fected with heterotypic Type l  virus (1). 4 of the 7 paralyzed monkeys, which ~.  CASALS,  P.  K.  OLITSKY~  AND  A.  B.  SABIN  57 
were bled shortly before or after death, developed CF antibodies, 2 of them as 
early as 2 days after onset of paralysis. The 3 monkeys which failed to develop 
TABLE I 
Dcoelo/yment of Horaotypic Complement-Fixing Antibody  in  Cynomolgus Monkeys  Infected 
with Y-SK Vir~ by Oral Route 
Group 
Paralytic, Died 
Bled just before or 
shortly after death 
Paralytic, Surdved 
~¢on-Paraiyti¢  15-58 
Poliomyelitis  le-  15--66 
sions  present  in  15-91 
CNS 
Neutralization 
Postinfection  serum  index  of serum 
Cyno- 
molgus  Time  Time 
No.  after  after  Before  After 
onset of  1st dose  infection  infection 
paralysis  of virus 
days  days 
15-76  2  12  4  160+ 
16-01  2  14  2  50 
16--02  4  18  2  50 
16-19  6  ]  15  2  200+ 
15-77  6  16  2  160+ 
15-98  6  17  2  160+ 
15-73  8  18  8  160+ 
16-08  16  28  2  50 
16-17x  18  28  1  50 
16-24x  18  28  1  40 
15--62  18  28  1  160+ 
16-OOx  20  28  50*  200+* 
28  1  100 
28  1  63 
29  4  130+ 
No poliomyelitis le-  15-61  --  28  1  130+ 
sions  15-68  --  28  2  80 
15-69  --  28  2  63 
15-83  --  29  8  130+ 
15-90  --  29  1  160+ 
CF titer of serum 
Before  After 
infection  infection 
0  1:4 
0  1:16 
AC (1:4)  1:16 
0  0 
0  1:64 
0  0 
0  0 
0  1:8 
0  1:16 
AC (1:4)  1:8 
AC (1:4)  1:16 
AC (1:4)  1:32 
0  I:C; 
0  1:64 
AC (1:8)  1:128 
0  (1:4)?~ 
AC (1:16)  1:8 
0  1:8 
0  1:8 
AC (1:4)  1:64 
* Cynomolgus 16-00x had a serum-dilution neutralizing  antibody titer against 50 LD~0of 
virus of 1:5 in the prelnfection serum and of 1:180+ in the postinfection serum. 
:~ These are the titers of the sera heated at 65°C. 
AC ffi anticomplementary. 
0 =  negative in 1:4 dilution. 
CF antibody died 6 to 8 days after onset of paralysis. The absence of CF anti- 
body in these 3 moribund or dead monkeys may be due to a  slower develop- 
ment of CF than of neutralizing antibody in some severely affected animals or 
to more extensive combination with CF antigen in the tissues of such animals, 
although it is possible that some animals, regardless of the severity of infection, 58  HOMOTYPIC  COMPLEMENT-FIXING  ANTIBODY  IN POLIO~[YELITIS 
may not develop CF antibody within 6 to 8 days after onset. It is noteworthy 
that the titer of CF antibody 2 to 6 days after onset of paralysis in the other 
moribund or dead monkeys was as high as that found in the surviving monkeys 
16 to 20 days after onset of paralysis. This early development of CF antibody 
in maximum titer in monkeys infected with homotypic Type 2 virus is similar 
to that found in human beings  developing  Type  2,  CF  antibody following 
infection with heterotypic Type 1 virus (1). These results suggest that the usual 
4-fold or greater rise in titer required for diagnostic purposes might be achieved 
only infrequently for the CF antibody in poliomyelitis. 
SVMmU~Y AND CONCLVSlONS 
CF tests with Type 2 poliomyelitis antigen (MEF1) were performed on the 
pre- and postinfection sera of 20 cynomolgus  monkeys which developed par- 
alytic, non-paralytic, or inapparent infection following oral administration of 
a Type 2 strain of virus (Y-SK). All the monkeys developed neutralizing anti- 
body, and  17  developed  CF  antibody in  an original serum dilution titer of 
1: 4 or greater. The 3 monkeys which did not develop this level of CF antibody 
were in a group of 7 which died within 8 days after onset of paralysis. The CF 
titers were as high at 2 to 6 days after onset of paralysis in the other 4 moribund 
or dead monkeys as in the surviving animals tested 16 to 20 days after onset 
of paralysis. All the surviving monkeys were tested 4 weeks after the first dose 
of virus and the CF titers were of the same order of magnitude in the groups 
with paralytic, non-paralytic, or inapparent infection. The Type 2 poliomyelitis 
CF titers developed in monkeys as a result of infection  with  homotypic virus 
were not greater than those found in human beings infected with heterotypic 
Type 1 poliomyelitis strains. 
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